FPRX

Q: What is the price of Five Prime Therapeutics (FPRX) today?

The current price of Five Prime Therapeutics (FPRX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Five Prime Therapeutics (FPRX) pay dividends?

Five Prime Therapeutics (FPRX) did not pay dividends over the past year.

Five Prime Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

p/bv

DIVIDEND YIELD

FPRX price

FPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment FPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals FPRX

review the fundamentals of Five Prime Therapeutics shares

P/E

Sector: -3.96 Industry: -3.96

P/S (PSR)

Sector: -3.88 Industry: -3.88

P/BV

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

Sector: - Industry: -

ROA

Sector: -61.39% Industry: -61.39%

ROE

Sector: -60.71% Industry: -60.71%

ROIC

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

0.00%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

0.00%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

0.00%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

0.00

Sector: -3.80 Industry: -3.80

EV/EBIT

0.00

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

0.00

Sector: 1.38 Industry: 1.38

BVPS

5.78

Sector: 1.89 Industry: 1.89

EPS

-1.84

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.80

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals FPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

FPRX Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Five Prime Therapeutics

Five Prime Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

25 years

Founded: 2001

2013

Time since IPO - 13 years

51

Employees

Five Prime Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $265.10 Millions.

The company employs approximately 51 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Five Prime Therapeutics Inc. reported $13.18 Millions in revenue, generating net income of $-84.33 Millions.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker FPRX.

Market cap

$ -

Net worth

$ 265.10 Millions

$ 265,100,000.00

Assets

$ 331.65 Millions

$ 331,650,000.00

Total Shares Outstanding

45.85 Millions

45,848,000

Average Daily Trading Volume

$ 3.03 Millions

$ 3,032,970.00

Sector

Health Care

Industry

Biotechnology

FPRX

FPRX revenue and profits

Financial Results FPRX

DRAG THE FRAME TO SEE MORE DATA

FPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 865.60 26,06% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 215.52 66,01% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 238.46 61,54% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 26.92 31,78% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 207.94 23,70% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 121.42 58,92% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 204.03 52,68% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 865.60 26,06% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 215.52 66,01% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 238.46 61,54% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 26.92 31,78% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 207.94 23,70% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 121.42 58,92% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 204.03 52,68% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

Frequently Asked Questions

What is the price of Five Prime Therapeutics (FPRX) today?

The current price of Five Prime Therapeutics (FPRX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Five Prime Therapeutics (FPRX) pay dividends?

Five Prime Therapeutics (FPRX) did not pay dividends over the past year.

Is Five Prime Therapeutics (FPRX) a good investment?

Five Prime Therapeutics (FPRX) is currently trading at $ 0.00 with a P/E ratio of 0.00%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Five Prime Therapeutics (FPRX) stock?

You can buy Five Prime Therapeutics (FPRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol FPRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Five Prime Therapeutics (FPRX) yield today?

Over the past month, Five Prime Therapeutics (FPRX) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.

If you were to purchase 100 shares of Five Prime Therapeutics (FPRX) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FPRX

Five Prime Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FPRX

review the fundamentals of Five Prime Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: %

5-year average DY: 0.00%

ABOUT Five Prime Therapeutics

Five Prime Therapeutics Inc.

United States

25 years

2013

51

Financial Results FPRX

FPRX cash flow

Asset, Revenue and Profit Growth - FPRX

FPRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions